Page 14 - Stephens Drive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Candel Therapeutics Announces Pricing of Initial Public Offering NEEDHAM, Mass., July 26, 2021 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (“Candel”), a late clinical stage biopharmaceutical company developing novel oncolytic viral immunotherapies, today announced the pricing of its initial public offering of 9,000,000 shares of common stock at a public offering price of $8.00 per share. The shares are expected to begin trading on the Nasdaq Global Market on July 27, 2021 under the ticker symbol “CADL.” The gross proceeds of the offering, before deducting underwriting discounts a...

Absci Announces Pricing of Initial Public Offering VANCOUVER, Wash., July 21, 2021 (GLOBE NEWSWIRE) — Absci Corporation (“Absci”), the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced the pricing of its initial public offering of 12,500,000 shares of common stock at a public offering price of $16.00 per share. All of the shares of common stock are being offered by Absci. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Absci, are expected to b...

Press release content from Business Wire. The AP news staff was not involved in its creation. IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock July 13, 2021 GMT NEW YORK--(BUSINESS WIRE)--Jul 12, 2021-- IVERIC bio, Inc. (Nasdaq: ISEE) (the “Company”), today announced the pricing of an underwritten public offering of 11,650,000 shares of its common stock at a price to the public of $8.60 per share, less underwriting discounts and commissions. In addition, in connection with the offering, the Company has granted the underwriters an option for a period of 30...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Acropolis Infrastructure Acquisition Corp. Announces Pricing of $300 Million Initial Public Offering Acropolis Infrastructure Acquisition Corp.July 8, 2021 GMT NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) -- Acropolis Infrastructure Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 30,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange (the “NYSE”) under the symbol “ACRO.U” commencing on July 9, 2021. Each un...

Acumen Pharmaceuticals Announces Pricing of Upsized Initial Public Offering June 30, 2021 22:44 ET | Source: Acumen Pharmaceuticals, Inc. Acumen Pharmaceuticals, Inc. Charlottesville, Virginia, UNITED STATES CHARLOTTESVILLE, Va., June 30, 2021 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (“Acumen” or “Acumen Pharmaceuticals”) (Nasdaq: ABOS), a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what Acumen believes to be a key underlying cause of Alzheimer’s disease, today announced the pr...